Cisternography with the non-ionic water-soluble contrast medium metrizamide. A preliminary report.
In 11 patients the basal cisterns in the posterior cranial fossa were examined with the new water-soluble compound metrizamide. Promising results were obtained when the medium was administered suboccipitally or through the foramen ovale but less favourable after lumbar administration. The clinical tolerance of the compound with regard to short term effects was good.
D000328:Adult; D002946:Cisterna Magna / Q000000981:diagnostic imaging*; D003388:Cranial Fossa, Posterior / Q000000981:diagnostic imaging*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007427:Intracranial Pressure / Q000187:drug effects; D007463:Iodobenzoates; D008297:Male; D008793:Metrizamide / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D011187:Posture; D011859:Radiography; D012886:Skull / Q000000981:diagnostic imaging*; D013268:Stimulation, Chemical
D007463:Iodobenzoates; D008793:Metrizamide